Original ArticleSafety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
Under a Creative Commons license
open access
Key words
atezolizumab
extensive-stage small-cell lung cancer
PD-L1
quality of life
safety
TECENTRIQ
Cited by (0)
© 2019 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.